Sangamo Therapeutics Announces Participation at H.C. Wainwright BIOCONNECT Virtual Conference

Rhea-AI Summary

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) has announced that management will present at the H.C. Wainwright BIOCONNECT Virtual Conference on January 10 at 7:00 a.m. Eastern Time. The presentation can be accessed via the company's website in the Investors and Media section and will be available for viewing post-event. Sangamo focuses on genomic medicine using proprietary zinc finger genome engineering technologies to develop new treatments for diseases lacking adequate options.

Positive

• Participation in a prominent conference like H.C. Wainwright BIOCONNECT highlights Sangamo's commitment to engaging with the investment community.
• The presentation opportunity may enhance Sangamo's visibility and attract potential investors.

Negative

• None.

BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will provide a corporate presentation at the H.C. Wainwright BIOCONNECT Virtual Conference on Monday, January 10^th at 7:00 a.m. Eastern Time.

The virtual session may be accessed on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will also be available on the Sangamo Therapeutics website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is a clinical-stage biopharmaceutical company with a robust genomic medicines pipeline. Using ground-breaking science, including our proprietary zinc finger genome engineering technology and manufacturing expertise, Sangamo aims to create new genomic medicines for patients suffering from diseases for which existing treatment options are inadequate or currently don’t exist. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220104005290/en/

Investor Relations & Media Inquiries

Aron Feingold

628.252.7494

afeingold@sangamo.com

Source: Sangamo Therapeutics, Inc.

FAQ

When is Sangamo Therapeutics presenting at the BIOCONNECT Virtual Conference?

Sangamo Therapeutics will present on January 10 at 7:00 a.m. Eastern Time.

Where can I find the presentation from Sangamo Therapeutics?

The presentation will be available on the Sangamo website in the Investors and Media section after the event.

What is the stock symbol for Sangamo Therapeutics?

The stock symbol for Sangamo Therapeutics is SGMO.

What type of company is Sangamo Therapeutics?

Sangamo Therapeutics is a clinical-stage biopharmaceutical company focused on genomic medicine.